VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 8 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,688 | +9.3% | 82,500 | +10.6% | 0.02% | +4.5% |
| Q2 2023 | $26,252 | +34.2% | 74,600 | +20.1% | 0.02% | +29.4% |
| Q1 2023 | $19,565 | -4.8% | 62,100 | -12.8% | 0.02% | -22.7% |
| Q4 2022 | $20,561 | -99.9% | 71,200 | -25.8% | 0.02% | -29.0% |
| Q3 2022 | $27,795,000 | +82.3% | 96,000 | +77.4% | 0.03% | +93.8% |
| Q2 2022 | $15,244,000 | -39.9% | 54,100 | -44.3% | 0.02% | -30.4% |
| Q1 2022 | $25,366,000 | +34.5% | 97,200 | +13.2% | 0.02% | +21.1% |
| Q4 2021 | $18,863,000 | +50.7% | 85,900 | +38.8% | 0.02% | +58.3% |
| Q3 2021 | $12,516,000 | +0.3% | 61,900 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $12,480,000 | -42.0% | 61,900 | +6083.8% | 0.01% | -69.2% |
| Q1 2021 | $21,510,000 | – | 1,001 | +67.4% | 0.04% | – |
| Q4 2020 | $0 | – | 598 | +79.0% | 0.00% | – |
| Q3 2020 | $0 | – | 334 | -12.1% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 380 | -39.5% | 0.00% | -100.0% |
| Q1 2020 | $14,943,000 | +2.2% | 628 | -6.0% | 0.03% | -18.8% |
| Q4 2019 | $14,625,000 | +51.5% | 668 | +17.2% | 0.03% | +18.5% |
| Q3 2019 | $9,656,000 | +14.2% | 570 | +23.6% | 0.03% | +17.4% |
| Q2 2019 | $8,453,000 | -3.3% | 461 | -2.9% | 0.02% | -4.2% |
| Q1 2019 | $8,737,000 | -10.9% | 475 | -19.8% | 0.02% | -17.2% |
| Q4 2018 | $9,810,000 | +18.9% | 592 | +38.3% | 0.03% | +11.5% |
| Q3 2018 | $8,249,000 | -4.6% | 428 | -15.9% | 0.03% | -23.5% |
| Q2 2018 | $8,650,000 | +6765.1% | 509 | +170.7% | 0.03% | +466.7% |
| Q1 2018 | $126,000 | +173.9% | 188 | -0.5% | 0.01% | +200.0% |
| Q4 2017 | $46,000 | -69.9% | 189 | -75.1% | 0.00% | -66.7% |
| Q3 2017 | $153,000 | -42.3% | 760 | +13.4% | 0.01% | -50.0% |
| Q2 2017 | $265,000 | +188.0% | 670 | -46.7% | 0.01% | +200.0% |
| Q1 2017 | $92,000 | -72.0% | 1,256 | +230.5% | 0.00% | -80.0% |
| Q4 2016 | $329,000 | +39.4% | 380 | +0.3% | 0.02% | +25.0% |
| Q3 2016 | $236,000 | +274.6% | 379 | +254.2% | 0.02% | +300.0% |
| Q2 2016 | $63,000 | -76.1% | 107 | -2.7% | 0.00% | -81.0% |
| Q1 2016 | $264,000 | +300.0% | 110 | -46.6% | 0.02% | +320.0% |
| Q4 2015 | $66,000 | -68.3% | 206 | +10.8% | 0.01% | -66.7% |
| Q3 2015 | $208,000 | +235.5% | 186 | +31.9% | 0.02% | +200.0% |
| Q2 2015 | $62,000 | -65.6% | 141 | -47.6% | 0.01% | -76.2% |
| Q1 2015 | $180,000 | +53.8% | 269 | -46.5% | 0.02% | +50.0% |
| Q4 2014 | $117,000 | – | 503 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMC-Chicago, LLC | 47,200 | $14,871,304 | 0.02% |
| SIMPLEX TRADING, LLC | 62,100 | $19,565 | 0.02% |
| GROUP ONE TRADING, L.P. | 14,300 | $4,505,501 | 0.02% |
| JANE STREET GROUP, LLC | 55,200 | $17,391,864 | 0.01% |
| Allianz Asset Management GmbH | 11,200 | $3,528,784 | 0.01% |
| SG Americas Securities, LLC | 11,000 | $130 | 0.00% |
| JPMORGAN CHASE & CO | 23,200 | $7,310,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |